Company Overview

Company name: Phoenix Bio Pharmaceutical
Description: Developer of pharmaceutical-grade botanical products. The company focuses on acquiring, developing and manufacturing medical delivery systems for human and animal applications of cannabinoid compounds. Through strategically appointed licensees and project partners, it is building a national network of production and distribution facilities in the United States, with a target of international expansion.
Year founded:
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Greenwood Village
State: Colorado
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Acquired/Merged
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company was acquired by Phoenix Life Sciences for an undisclosed amount on January 31, 2017.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: